Boehringer Ingelheim appoints Zong Chen as the company's CEO.

On April 16th, Haebio Pharmaceuticals officially appointed Zong Chen as the company's president. Zong Chen will be based in Shanghai and report directly to Haebio Pharmaceuticals founder, chairman, and CEO Wang Jinsong. During his tenure, Zong Chen will be responsible for strengthening the internal product pipeline of Haebio Pharmaceuticals, advancing the strategic layout of the overall product portfolio, and leading asset strategy and external cooperation affairs.